{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:53:22Z","timestamp":1772744002100,"version":"3.50.1"},"reference-count":161,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.pharmthera.2012.08.004","type":"journal-article","created":{"date-parts":[[2012,8,11]],"date-time":"2012-08-11T07:15:39Z","timestamp":1344669339000},"page":"153-168","source":"Crossref","is-referenced-by-count":37,"title":["Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma"],"prefix":"10.1016","volume":"136","author":[{"given":"Fergal C.","family":"Kelleher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason E.","family":"Cain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan M.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Neil","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jcp.2004.017640","article-title":"An immunohistochemical analysis to evaluate an inverse correlation between Runx2\/Cbfa1 and NF kappa B in human osteosarcoma","volume":"58","author":"Andela","year":"2005","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ng0293-113","article-title":"Rearrangement of the PAX3 paired box gene in the pediatric solid tumour alveolar rhabdomyosarcoma","volume":"3","author":"Barr","year":"1993","journal-title":"Nat Genet"},{"issue":"14","key":"10.1016\/j.pharmthera.2012.08.004_bb0020","doi-asserted-by":"crossref","first-page":"9074","DOI":"10.1074\/jbc.M806233200","article-title":"GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein","volume":"284(","author":"Beauchamp","year":"2009","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mpo.2950110309","article-title":"Case report: nasopharyngeal rhabdomyosarcoma and Gorlin's naevoid basal cell carcinoma syndrome","volume":"11","author":"Beddis","year":"1983","journal-title":"Med Pediatr Oncol"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.08.004_bb0035","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1158\/1541-7786.MCR-08-0176","article-title":"The retinoblastoma protein tumor suppressor is important for appropriate osteoblast differentiation and bone development","volume":"6","author":"Berman","year":"2008","journal-title":"Mol Cancer Res"},{"issue":"7283","key":"10.1016\/j.pharmthera.2012.08.004_bb0040","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.08.004_bb0045","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2105::AID-CNCR9>3.0.CO;2-U","article-title":"Primary chondrosarcoma of long bones and limb girdles","volume":"83","author":"Bj\u00f6rnsson","year":"1998","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.08.004_bb0055","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1470-2045(05)70282-5","article-title":"Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment","volume":"6","author":"Bov\u00e9e","year":"2005","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.08.004_bb0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc2869","article-title":"Cartilage tumors and bone development: molecular pathology and possible therapeutic targets","volume":"10","author":"Bov\u00e9e","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1098-2264(200004)27:4<337::AID-GCC1>3.0.CO;2-1","article-title":"Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study","volume":"27","author":"Bridge","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.004_rf0785","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1101\/gad.1640908","article-title":"Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma","volume":"22","author":"Briggs","year":"2008","journal-title":"Genes Dev"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.08.004_rf0790","first-page":"1410","volume":"22","year":"2008","journal-title":"Genes Dev"},{"issue":"51","key":"10.1016\/j.pharmthera.2012.08.004_bb0070","doi-asserted-by":"crossref","first-page":"51ra70","DOI":"10.1126\/scitranslmed.3001599","article-title":"Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma","volume":"2","author":"Buonamici","year":"2010","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.08.004_bb0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ncponc0608","article-title":"Rhabdomyosarcoma, Wilms tumor, and deletion of the patched gene in Gorlin syndrome","volume":"3","author":"Cajaiba","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/humu.9056","article-title":"Analysis of the PTCH coding region in human rhabdomyosarcoma","volume":"20","author":"Calzada-Wack","year":"2002","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_bb0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2008.09.039","article-title":"Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?","volume":"279","author":"Charytonowicz","year":"2009","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12094-012-0784-4","article-title":"PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation","volume":"14","author":"Charytonowicz","year":"2012","journal-title":"Clin Transl Oncol"},{"issue":"15","key":"10.1016\/j.pharmthera.2012.08.004_bb0100","doi-asserted-by":"crossref","first-page":"8650","DOI":"10.1073\/pnas.151236498","article-title":"Subnuclear targeting of Runx\/Cbfa\/AML factors is essential for tissue-specific differentiation during embryonic development","volume":"98","author":"Choi","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1034\/j.1399-0020.1999.283280314.x","article-title":"Nevoid basal cell carcinoma syndrome: molecular biology and new hypotheses","volume":"28","author":"Cohen","year":"1999","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"12","key":"10.1016\/j.pharmthera.2012.08.004_bb0110","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S1474-4422(07)70289-2","article-title":"Medulloblastoma in childhood: new biological advances","volume":"6","author":"Crawford","year":"2007","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.004_bb0115","first-page":"875","article-title":"The Patched gene is epigenetically regulated in ovarian dermoids and fibromas, but not in basocellular carcinomas","volume":"19","author":"Cretnik","year":"2007","journal-title":"Int J Mol Med"},{"issue":"22","key":"10.1016\/j.pharmthera.2012.08.004_bb0120","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1158\/1078-0432.CCR-05-1354","article-title":"Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways","volume":"11","author":"Cutcliffe","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.08.004_bb0125","first-page":"2869","article-title":"Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma","volume":"54","author":"Davis","year":"1994","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.004_bb0130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-2143(99)90097-5","article-title":"Increase in nucleoli after x-radiation of fibroblasts of patients with Gorlin syndrome","volume":"134","author":"Dezawa","year":"1999","journal-title":"Lab Clin Med"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0135","doi-asserted-by":"crossref","DOI":"10.2350\/11-01-0968-OA.1","article-title":"Clear cell sarcoma of kidney: morphoproteomic analysis reveals genomic correlates and therapeutic options","author":"Dhamne","year":"2012","journal-title":"Pediatr Dev Pathol"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1073\/pnas.0907606106","article-title":"DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences","volume":"107","author":"Diede","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.08.004_bb0145","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1614","article-title":"Essential role of stromally induced hedgehog signaling in B-cell malignancies","volume":"13","author":"Dierks","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0155","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/mc.20394","article-title":"Cyclopamine treatment of full-blown Hh\/Ptch-associated RMS partially inhibits Hh\/Ptch signalling, but not tumor growth","volume":"47","author":"Ecke","year":"2008","journal-title":"Mol Carcinog"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.08.004_bb0160","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrc2503","article-title":"Basal cell carcinomas: attack of the hedgehog","volume":"8","author":"Epstein","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_bb0170","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B","article-title":"Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading","volume":"40","author":"Evans","year":"1977","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.004_bb0165","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/bjc.1991.435","article-title":"The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma","volume":"64","author":"Evans","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2164-8-73","article-title":"Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential","volume":"8","author":"Francis","year":"2007","journal-title":"BMC Genomics"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.004_bb0185","first-page":"1381","article-title":"Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines","volume":"34","author":"Fujii","year":"2009","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ng0996-78","article-title":"The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas","volume":"14","author":"Gailani","year":"1996","journal-title":"Nat Genet"},{"issue":"18","key":"10.1016\/j.pharmthera.2012.08.004_bb0200","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1038\/onc.2011.418","article-title":"Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2","volume":"31","author":"Garcia","year":"2012","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_rf0805","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1634\/theoncologist.2007-0237","article-title":"The clinical approach towards chondrosarcoma","volume":"13","author":"Gelderblom","year":"2008","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.004_rf0810","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1634\/theoncologist.2007-0237erratum","volume":"13","year":"2008","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.08.004_bb0210","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregional sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"issue":"7327","key":"10.1016\/j.pharmthera.2012.08.004_bb0215","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nature09587","article-title":"Subtypes of medulloblastoma have distinct developmental origins","volume":"468","author":"Gibson","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0220","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(04)01424-X","article-title":"Medulloblastoma: signalling a change in treatment","volume":"5","author":"Gilbertson","year":"2004","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.004_rf0820","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-2143(99)90092-6","article-title":"Nevoid basal cell carcinoma (Gorlin) syndrome: unanswered issues","volume":"134","author":"Gorlin","year":"1999","journal-title":"J Lab Clin Med"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.004_rf0825","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-2143(99)90097-5","volume":"134","year":"1999","journal-title":"J Lab Clin Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0235","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1101\/gad.940702","article-title":"Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification","volume":"16","author":"Gustafsson","year":"2002","journal-title":"Genes Dev"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.004_bb0245","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0092-8674(00)81268-4","article-title":"Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome","volume":"85","author":"Hahn","year":"1996","journal-title":"Cell"},{"issue":"37","key":"10.1016\/j.pharmthera.2012.08.004_bb0250","doi-asserted-by":"crossref","first-page":"28341","DOI":"10.1074\/jbc.C000352200","article-title":"Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma","volume":"275","author":"Hahn","year":"2000","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.004_bb0255","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nm0598-619","article-title":"Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome","volume":"4","author":"Hahn","year":"1998","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0260","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1897-4287-2-4-161","article-title":"Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management","volume":"2","author":"Hameetman","year":"2004","journal-title":"Hered Cancer Clin Pract"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0265","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/path.2008","article-title":"Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling","volume":"209","author":"Hameetman","year":"2006","journal-title":"J Pathol"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.08.004_bb0275","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1158\/1078-0432.CCR-11-0755","article-title":"Molecular pathways: the role of primary cilia in cancer progression and therapeutics with a focus on hedgehog signaling","volume":"18(","author":"Hassounah","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0280","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/374318","article-title":"Homozygous mutations in IHH cause acrocapitofemoral dysplasia, an autosomal recessive disorder with cone-shaped epiphyses in hands and hips","volume":"72","author":"Hellemans","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.004_bb0285","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.devcel.2005.02.013","article-title":"Canonical Wnt\/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes","volume":"8","author":"Hill","year":"2005","journal-title":"Dev Cell"},{"issue":"12","key":"10.1016\/j.pharmthera.2012.08.004_bb0290","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/sj.bjc.6605407","article-title":"Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells","volume":"101","author":"Hirotsu","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-9-5","article-title":"Smoothened as a new therapeutic target for human osteosarcoma","volume":"9","author":"Hirotsu","year":"2010","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_bb0300","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ccr.2009.05.013","article-title":"Gli2 and p53 cooperate to regulate IGFBP-3\u2010mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors","volume":"16","author":"Ho","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0305","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.2741\/2296","article-title":"Signaling and transcriptional regulation in osteoblast commitment and differentiation","volume":"12","author":"Huang","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0315","unstructured":"Infinity Pharmaceuticals. Infinity Stops Phase 2 Trials of Saridegib in Chondrosarcoma and Myelofibrosis\u2014Company to Focus on Ongoing Development of Retaspimycin HCl and IPI-145. Press Release 2012."},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0320","unstructured":"Infinity Pharmaceuticals. Infinity reports update from phase 2 study of Saridegib plus gemcitabine in patients with metastatic pancreatic cancer\u2014Infinity stops phase 2 study following preliminary analysis showing trial would not meet primary endpoint of overall survival. Press release 2012."},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dna.2006.0505","article-title":"Molecular pathogenesis of osteosarcoma","volume":"26","author":"Kansara","year":"2007","journal-title":"DNA Cell Biol"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb1000","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/path.1361","article-title":"Molecular characterization of Patched associated rhabdomyosarcoma","volume":"200","author":"Kappler","year":"2003","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0345","first-page":"899","article-title":"Pharmacological inhibition of the hedgehog pathway prevents human rhabdomyosarcoma cell growth","volume":"39","author":"Kawabata","year":"2011","journal-title":"Int J Oncol"},{"issue":"23","key":"10.1016\/j.pharmthera.2012.08.004_bb0350","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.1073\/pnas.96.23.13264","article-title":"cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene","volume":"96","author":"Khan","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"10.1016\/j.pharmthera.2012.08.004_bb0355","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.1006822107","article-title":"Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector","volume":"107","author":"Kim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0923-1811(01)00170-0","article-title":"Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias","volume":"29","author":"Kim","year":"2002","journal-title":"J Dermatol Sci"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0360","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ccr.2010.02.027","article-title":"Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth","volume":"17","author":"Kim","year":"2010","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0370","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M","article-title":"Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome","volume":"69","author":"Kimonis","year":"1997","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0375","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2008.01.027","article-title":"Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure","volume":"13","author":"Kimura","year":"2008","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.pharmthera.2012.08.004_bb0380","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s00018-005-5072-9","article-title":"Pleiotropic effects of sonic hedgehog on muscle satellite cells","volume":"62","author":"Koleva","year":"2005","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.004_bb0385","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","article-title":"Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts","volume":"89","author":"Komori","year":"1997","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_bb0390","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/pbc.22730","article-title":"Posterior fossa syndrome after posterior fossa surgery in children with brain tumours","volume":"56","author":"K\u00fcpeli","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"20","key":"10.1016\/j.pharmthera.2012.08.004_bb0400","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.0609699104","article-title":"Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists","volume":"104","author":"Lauth","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"10.1016\/j.pharmthera.2012.08.004_bb0405","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1038\/sj.onc.1210467","article-title":"Loss of suppressor-of-fused function promotes tumorigenesis","volume":"26","author":"Lee","year":"2007","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.pharmthera.2012.08.004_bb0410","first-page":"5428","article-title":"A molecular fingerprint for medulloblastoma","volume":"63","author":"Lee","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0420","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1196\/annals.1329.017","article-title":"Role of the hedgehog\/patched signaling pathway in oncogenesis: a new polymorphism in the PTCH gene in ovarian fibroma","volume":"1030","author":"Levanat","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_bb0425","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/geno.1994.1519","article-title":"AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization","volume":"23","author":"Levanon","year":"1994","journal-title":"Genomics"},{"issue":"14","key":"10.1016\/j.pharmthera.2012.08.004_bb0430","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1158\/0008-5472.CAN-08-3580","article-title":"Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma","volume":"69","author":"Levings","year":"2009","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.pharmthera.2012.08.004_bb0435","doi-asserted-by":"crossref","first-page":"e15262","DOI":"10.1371\/journal.pone.0015262","article-title":"Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926","volume":"5","author":"Lin","year":"2010","journal-title":"PLoS One"},{"issue":"34","key":"10.1016\/j.pharmthera.2012.08.004_bb0440","doi-asserted-by":"crossref","first-page":"26233","DOI":"10.1074\/jbc.M110.122069","article-title":"Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3-kinase\/Akt\/RUNX2 pathway","volume":"285","author":"Ling","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0445","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/toxsci\/kfn076","article-title":"Dose- and route-dependent teratogenicity, toxicity, and pharmacokinetic profiles of the hedgehog signaling antagonist cyclopamine in the mouse","volume":"104","author":"Lipinski","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0530","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1399-0004.1999.550106.x","article-title":"Nevoid basal cell carcinoma syndrome. Clinical findings in 37 Italian affected individuals","volume":"55","author":"Lo Muzio","year":"1999","journal-title":"Clin Genet"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.004_bb0450","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1242\/dev.01006","article-title":"Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton","volume":"131","author":"Long","year":"2004","journal-title":"Development"},{"issue":"24","key":"10.1016\/j.pharmthera.2012.08.004_bb0455","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1242\/dev.128.24.5099","article-title":"Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation","volume":"128","author":"Long","year":"2001","journal-title":"Development"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.08.004_bb0460","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMe1200656","article-title":"Tumor heterogeneity and personalized medicine","volume":"366","author":"Longo","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0470","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/hmg\/ddn383","article-title":"A Runx2 threshold for the cleidocranial dysplasia phenotype","volume":"18","author":"Lou","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.004_bb0475","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1158\/1541-7786.MCR-07-2115","article-title":"Cell cycle regulator gene CDC5L, a potential target for 6p12\u2013p21 amplicon in osteosarcoma","volume":"6","author":"Lu","year":"2008","journal-title":"Mol Cancer Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0480","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1535-6108(02)00132-0","article-title":"Focus on sarcomas","volume":"2","author":"Mackall","year":"2002","journal-title":"Cancer Cell"},{"issue":"15","key":"10.1016\/j.pharmthera.2012.08.004_bb0485","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1073\/pnas.0608449104","article-title":"Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone","volume":"104","author":"Maeda","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.pharmthera.2012.08.004_bb0490","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1021\/jm801420y","article-title":"Hedgehog-Gli signalling pathway inhibitors as anticancer agents","volume":"52","author":"Mahindroo","year":"2009","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0495","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1593\/neo.81384","article-title":"Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma","volume":"11","author":"Maire","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0500","doi-asserted-by":"crossref","first-page":"282745","DOI":"10.1155\/2011\/282745","article-title":"The role of RUNX2 in osteosarcoma oncogenesis","volume":"2011","author":"Martin","year":"2011","journal-title":"Sarcoma"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb2000","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1083\/jcb.200907126","article-title":"Lateral transport of Smoothened from the plasma membrane to the membrane of the cilium","volume":"187","author":"Milenkovic","year":"2009","journal-title":"J Cell Biol"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0515","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1128\/MCB.01401-09","article-title":"Selective signaling by Akt2 promotes bone morphogenetic protein 2-mediated osteoblast differentiation","volume":"30","author":"Mukherjee","year":"2010","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0520","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/hmg\/4.1.71","article-title":"Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family","volume":"4","author":"Mundlos","year":"1995","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.08.004_bb0525","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/sj.bjc.6605330","article-title":"Side population cells have the characteristics of cancer stem-like cells\/cancer-initiating cells in bone sarcomas","volume":"101","author":"Murase","year":"2009","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_bb0535","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/path.2880","article-title":"Role of GLI2 in the growth of human osteosarcoma","volume":"224","author":"Nagao","year":"2011","journal-title":"J Pathol"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.08.004_bb0540","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrc3079","article-title":"The Hedgehog's tale: developing strategies for targeting cancer","volume":"11","author":"Ng","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"43","key":"10.1016\/j.pharmthera.2012.08.004_bb0550","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1038\/onc.2011.157","article-title":"Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice","volume":"30","author":"Nitzki","year":"2011","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.08.004_bb0555","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","article-title":"Medulloblastoma comprises four distinct molecular variants","volume":"29","author":"Northcott","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.004_bb0560","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","article-title":"Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development","volume":"89","author":"Otto","year":"1997","journal-title":"Cell"},{"issue":"6016","key":"10.1016\/j.pharmthera.2012.08.004_bb0570","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1126\/science.1198056","article-title":"The genetic landscape of the childhood cancer medulloblastoma","volume":"331","author":"Parsons","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0575","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/cmdc.201000011","article-title":"Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics","volume":"5","author":"Peukert","year":"2010","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.004_bb0580","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/pbc.23174","article-title":"Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group","volume":"57","author":"Pressey","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_rf0865","first-page":"401","article-title":"Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma","volume":"19","author":"Ragazzini","year":"2004","journal-title":"Histol Histopathol"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_rf0870","first-page":"1013","volume":"19","year":"2004","journal-title":"Histol Histopathol"},{"issue":"36","key":"10.1016\/j.pharmthera.2012.08.004_bb0590","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1038\/sj.onc.1207818","article-title":"Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice","volume":"23","author":"Rao","year":"2004","journal-title":"Oncogene"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2012.08.004_bb0595","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2011.12.013","article-title":"Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations","volume":"148","author":"Rausch","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0600","series-title":"Pathology and Genetics of Tumours of Soft Tissue and Bone","first-page":"264","article-title":"Conventional osteosarcoma","author":"Raymond","year":"2002"},{"issue":"12","key":"10.1016\/j.pharmthera.2012.08.004_bb0605","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0504337103","article-title":"Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling","volume":"103","author":"Riob\u00f3","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.pharmthera.2012.08.004_bb0610","first-page":"5407","article-title":"Amplification of the gli gene in childhood sarcomas","volume":"49","author":"Roberts","year":"1989","journal-title":"Cancer Res"},{"issue":"16","key":"10.1016\/j.pharmthera.2012.08.004_bb0615","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1242\/dev.02480","article-title":"Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors","volume":"133","author":"Rodda","year":"2006","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0620","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1196-357","article-title":"Mutations in the human Sonic Hedgehog gene cause holoprosencephaly","volume":"14","author":"Roessler","year":"1996","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0625","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccr.2004.08.019","article-title":"Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+\/\u2212)p53(\u2212\/\u2212) mice","volume":"6","author":"Romer","year":"2004","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.08.004_bb0635","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrm952","article-title":"Intraflagellar transport","volume":"3","author":"Rosenbaum","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0640","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/path.1723","article-title":"Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas","volume":"205","author":"Rozeman","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0415","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/path.1723","article-title":"Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas","volume":"205","author":"Rozeman","year":"2005","journal-title":"J Pathol"},{"issue":"21","key":"10.1016\/j.pharmthera.2012.08.004_bb0645","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMra044151","article-title":"Basal-cell carcinoma","volume":"353","author":"Rubin","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0650","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1535-6108(02)00090-9","article-title":"Medulloblastoma: a problem of developmental biology","volume":"2","author":"Rubin","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0670","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1471-2407-10-202","article-title":"Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy","volume":"10","author":"Sadikovic","year":"2010","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.08.004_bb0675","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1101\/gad.13.11.1361","article-title":"FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway","volume":"13","author":"Sahni","year":"1999","journal-title":"Genes Dev"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.08.004_bb0685","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1158\/0008-5472.CAN-07-0493","article-title":"Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor","volume":"67","author":"Sasai","year":"2007","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.08.004_bb0680","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/0008-5472.CAN-05-4505","article-title":"Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies","volume":"66","author":"Sasai","year":"2006","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.004_bb0695","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tips.2009.03.007","article-title":"Mechanisms of Hedgehog pathway activation in cancer and implications for therapy","volume":"30","author":"Scales","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0700","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.cellbio.19.111401.091318","article-title":"Intraflagellar transport","volume":"19","author":"Scholey","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_bb0710","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccr.2008.07.005","article-title":"Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma","volume":"14","author":"Sch\u00fcller","year":"2008","journal-title":"Cancer Cell"},{"issue":"22","key":"10.1016\/j.pharmthera.2012.08.004_bb0715","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1242\/dev.056358","article-title":"Hedgehog signaling regulates the generation of ameloblast progenitors in the continuously growing mouse incisor","volume":"137","author":"Seidel","year":"2010","journal-title":"Development"},{"issue":"23","key":"10.1016\/j.pharmthera.2012.08.004_bb0720","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of Vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0725","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pbc.23391","article-title":"Evaluation of arsenic trioxide by the pediatric preclinical testing program with a focus on Ewing sarcoma","volume":"59","author":"Smith","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"16","key":"10.1016\/j.pharmthera.2012.08.004_rf0905","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1101\/gad.13.16.2072","article-title":"Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation","volume":"13","author":"St-Jacques","year":"1999","journal-title":"Genes Dev"},{"issue":"19","key":"10.1016\/j.pharmthera.2012.08.004_rf0910","first-page":"2617","volume":"13","year":"1999","journal-title":"Genes Dev"},{"issue":"7039","key":"10.1016\/j.pharmthera.2012.08.004_bb0740","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nature03494","article-title":"FGF-induced vesicular release of Sonic hedgehog and retinoic acid in leftward nodal flow is critical for left\u2013right determination","volume":"435","author":"Tanaka","year":"2005","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.pharmthera.2012.08.004_bb0745","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMoa1113538","volume":"366","author":"Tang","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.004_bb0750","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1083\/jcb.200409187","article-title":"Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma","volume":"167","author":"Thomas","year":"2004","journal-title":"J Cell Biol"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb3000","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jcb.20850","article-title":"Epigenetic modifications in osteogenic differentiation and transformation","volume":"98","author":"Thomas","year":"2006","journal-title":"J Cell Biochem"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.08.004_bb0760","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1073\/pnas.0813203106","article-title":"Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis","volume":"106","author":"Tian","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0765","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2353\/ajpath.2006.050001","article-title":"Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation","volume":"168","author":"Tiet","year":"2006","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.004_bb0770","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccr.2007.02.027","article-title":"Mesenchymal stem cell features of Ewing tumors","volume":"11","author":"Tirode","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2012.03.005","article-title":"Mesenchymal stem cell signaling in cancer progression","author":"Torsvik","year":"2012","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0780","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.1882","article-title":"Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development","volume":"208","author":"Tostar","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.pharmthera.2012.08.004_bb0785","first-page":"4611","article-title":"A novel HH pathway inhibitor, IPI-926, delays recurrence post-chemotherapy in a primary human SCLC xenograft model","author":"Travaglione","year":"2008"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0790","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.2011.37.8588","article-title":"Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications","volume":"30","author":"van Gaal","year":"2012","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.004_bb0795","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ccr.2011.03.010","article-title":"High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF\/\u03b2-catenin target gene, CDC25A","volume":"19","author":"Vijayakumar","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0885","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jcb.22536","article-title":"FGF signalling as a mediator of lineage transitions\u2014evidence from embryonic stem cell differentiation","volume":"110","author":"Villegas","year":"2010","journal-title":"J Cell Biochem"},{"issue":"12","key":"10.1016\/j.pharmthera.2012.08.004_bb0800","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","article-title":"Inhibition of the hedgehog pathway in advanced basal-cell carcinoma","volume":"361","author":"Von Hoff","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.004_bb0895","doi-asserted-by":"crossref","DOI":"10.4161\/cbt.8.6.7695","article-title":"Characterization of stem cell attributes in human osteosarcoma cell lines","volume":"8","author":"Wang","year":"2009","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.004_bb0815","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ccr.2010.11.007","article-title":"Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+\/\u2212) mice","volume":"19","author":"Wang","year":"2011","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.004_bb0810","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/0008-5472.CAN-11-2531","article-title":"Hedgehog and Notch signaling regulate self-renewal of undifferentiated pleomorphic sarcomas","volume":"72","author":"Wang","year":"2012","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0825","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/hupa.2003.41","article-title":"Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors","volume":"34","author":"Wehrli","year":"2003","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.08.004_bb0830","first-page":"2239","article-title":"The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched","volume":"60","author":"Wetmore","year":"2000","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_bb0835","first-page":"513","article-title":"Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched","volume":"61","author":"Wetmore","year":"2001","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.pharmthera.2012.08.004_bb0840","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1200\/JCO.2009.26.3814","article-title":"Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma","volume":"28","author":"Williamson","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.004_bb0850","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/030089160909500307","article-title":"Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma","volume":"95","author":"Won","year":"2009","journal-title":"Tumori"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.08.004_bb0845","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm.2011","article-title":"Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis","volume":"15","author":"Wong","year":"2009","journal-title":"Nat Med"},{"issue":"6662","key":"10.1016\/j.pharmthera.2012.08.004_bb0855","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/34201","article-title":"Activating Smoothened mutations in sporadic basal-cell carcinoma","volume":"391","author":"Xie","year":"1998","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.08.004_bb0860","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1007\/s11999-008-0332-2","article-title":"Patched-one or smoothened gene mutations are infrequent in chondrosarcoma","volume":"466","author":"Yan","year":"2008","journal-title":"Clin Orthop Relat Res"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.08.004_bb0865","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ng.192","article-title":"Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt\/beta3-catenin signaling","volume":"40","author":"Yang","year":"2008","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_bb0875","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2008.07.003","article-title":"Medulloblastoma can be initiated by deletion of P in lineage-restricted progenitors or stem cells","volume":"14","author":"Yang","year":"2008","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.004_bb0870","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00428-011-1108-8","article-title":"Mediastinal fetal rhabdomyoma in nevoid basal cell carcinoma syndrome: a case report and review of the literature","volume":"459","author":"Yang","year":"2011","journal-title":"Virchows Arch"},{"issue":"7211","key":"10.1016\/j.pharmthera.2012.08.004_bb0880","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature07275","article-title":"A paracrine requirement for hedgehog signalling in cancer","volume":"455","author":"Yauch","year":"2008","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.08.004_bb0890","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1101\/gad.1174704","article-title":"Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog","volume":"18","author":"Yoshida","year":"2004","journal-title":"Genes Dev"},{"issue":"7239","key":"10.1016\/j.pharmthera.2012.08.004_bb0905","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia","volume":"458","author":"Zhao","year":"2009","journal-title":"Nature"},{"issue":"48","key":"10.1016\/j.pharmthera.2012.08.004_bb0900","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1038\/onc.2010.368","article-title":"Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma","volume":"29","author":"Zibat","year":"2010","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.pharmthera.2012.08.004_bb0910","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1038\/sj.onc.1210991","article-title":"The EWS\/FLI1 oncogenic transcription factor deregulates GLI1","volume":"27","author":"Zwerner","year":"2008","journal-title":"Oncogene"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T10:06:51Z","timestamp":1714298811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725812001659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":161,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0163725812001659"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2012.08.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}